Javascript must be enabled to continue!
Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells
View through CrossRef
AbstractWe have compared the biological and biochemical properties of recombinant PDGF AA, AB, and BB using three types of fibroblastic cells: NIH/3T3, human skin fibroblast, and fetal bovine aortic smooth muscle. PDGF binding, receptor autophosphorylation, phosphatidyl inositol hydrolysis, as well as chemotactic and mitogenic responses of the cells were analyzed. PDGF‐AB and PDGF‐BB showed similar receptor binding, receptor autophosphorylation, and potent biological activity for all three of the cell types tested. In contrast, PDGF‐AA was biologically active only for the NIH/3T3 cells in which binding sites for PDGF‐AA were abundant, but was inactive for bovine aortic smooth muscle cells and human skin fibroblasts in which binding sites for PDGF‐AA were absent. PDGF‐AA could not induce any biochemical changes in the human skin fibroblasts or smooth muscle cells. Western blot studies with anti‐Type α and β PDGF receptor antibodies indicate that the NIH/3T3 cells contained both PDGF α and β receptors, whereas the human skin fibroblasts and bovine smooth muscle cells contained only detectable levels of β receptors. These results indicate that cells possessing high levels of PDGF β receptors only are capable of responding equally well to either PDGF AB or BB.
Title: Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells
Description:
AbstractWe have compared the biological and biochemical properties of recombinant PDGF AA, AB, and BB using three types of fibroblastic cells: NIH/3T3, human skin fibroblast, and fetal bovine aortic smooth muscle.
PDGF binding, receptor autophosphorylation, phosphatidyl inositol hydrolysis, as well as chemotactic and mitogenic responses of the cells were analyzed.
PDGF‐AB and PDGF‐BB showed similar receptor binding, receptor autophosphorylation, and potent biological activity for all three of the cell types tested.
In contrast, PDGF‐AA was biologically active only for the NIH/3T3 cells in which binding sites for PDGF‐AA were abundant, but was inactive for bovine aortic smooth muscle cells and human skin fibroblasts in which binding sites for PDGF‐AA were absent.
PDGF‐AA could not induce any biochemical changes in the human skin fibroblasts or smooth muscle cells.
Western blot studies with anti‐Type α and β PDGF receptor antibodies indicate that the NIH/3T3 cells contained both PDGF α and β receptors, whereas the human skin fibroblasts and bovine smooth muscle cells contained only detectable levels of β receptors.
These results indicate that cells possessing high levels of PDGF β receptors only are capable of responding equally well to either PDGF AB or BB.
Related Results
Effect of Imatinib on Proliferation, Apoptosis and Expression of Platelet Derived Growth Factor Receptor By Mesenchymal Stem Cells
Effect of Imatinib on Proliferation, Apoptosis and Expression of Platelet Derived Growth Factor Receptor By Mesenchymal Stem Cells
Abstract
Introduction
Imatinib Mesylate (IM) is a tyrosine kinase inhibitor (TKI), which targets Platelet Derived Growth Factor Receptor (PDGF-R), c-k...
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Functional Regulation of Adipose-Derived Stem Cells by PDGF-D
Abstract
Platelet-derived growth factor-D (PDGF-D) was recently identified, and acts as potent mitogen for mesenchymal cells. PDGF-D also induces cellular transforma...
Recombinant PDGF-BB Enhances Platelet Recovery in Mice with Radiation Induced Thromobocytopenia.
Recombinant PDGF-BB Enhances Platelet Recovery in Mice with Radiation Induced Thromobocytopenia.
Abstract
Platelet-derived growth factor (PDGF) involves in the regulation of hematopoietic stem cells. Imatinib mesylate (Gleevec), a PDGF receptor inhibitor, induce...
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
PDGF-BB and Its Role in Megakaryopoiesis and Thrombocythemia
Abstract
Background: Essential Thrombocythemia (ET) is characterized by persistently elevated platelet counts in the context of a normal red cell mass. However, the ...
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rA...
Galectin-1 Attenuates PDGF-Mediated AKT Signaling in Retinal Pigment Epithelial Cells
Galectin-1 Attenuates PDGF-Mediated AKT Signaling in Retinal Pigment Epithelial Cells
Galectins have the potential to interact with transmembrane glycoproteins to modulate their functions. Since galectin-1 interacts with PDGF-Rβ, we analyzed the effect of galectin-1...
Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity
Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity
AbstractProtamine sulfate blocked 125I‐PDGF binding to its specific physiological receptor on Swiss mouse 3T3 cells. Reduced 125I‐PDGF binding in the presence of protamine sulfate ...
Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression
Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression
ABSTRACT
We have examined the role of platelet-derived growth factor (PDGF) ligand and receptor genes in the angiogenic process of the developing human placenta. In ...

